Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

26 Dec, EOD - Indian

SENSEX 78472.48 (0.00)

Nifty 50 23750.2 (0.10)

Nifty Bank 51170.7 (-0.12)

Nifty IT 43664.25 (-0.01)

Nifty Midcap 100 57125.7 (0.12)

Nifty Next 50 69165.85 (0.45)

Nifty Pharma 22712.55 (0.68)

Nifty Smallcap 100 18728.65 (-0.02)

26 Dec, EOD - Global

NIKKEI 225 39568.06 (1.12)

HANG SENG 20098.29 (1.08)

S&P 6090 (-0.33)

Cancel

BSE Code : 532296 | NSE Symbol : GLENMARK | ISIN : INE935A01035 | Industry : Pharmaceuticals |

(16-Dec-24 09:41) Glenmark Pharma arm launches seizure drug in US
(16-Dec-24 09:06) Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution
(03-Dec-24 13:06) Glenmark Pharmaceuticals Ltd up for third straight session
(27-Nov-24 09:59) Glenmark Pharma arm launches Travoprost Ophthalmic Solution in U.S market
(27-Nov-24 09:12) Glenmark Pharma launches Travoprost Ophthalmic Solution USP
(18-Nov-24 13:35) Glenmark Pharmaceuticals Ltd eases for fifth straight session
(15-Nov-24 14:40) Glenmark Pharma reports turnaround Q2 results
(15-Nov-24 09:56) Glenmark Pharmaceuticals reports consolidated net profit of Rs 354.21 crore in the September 2024 quarter
(15-Nov-24 07:42) Glenmark Pharmaceuticals standalone net profit rises 96.81% in the September 2024 quarter
(06-Nov-24 13:05) Glenmark Pharmaceuticals Ltd gains for third straight session

1 2 3 4 5 6 7 8 9 10

Glenmark Pharmaceuticals Ltd